Autor: |
Deepak Dabkara, Sandip Ganguly, Joydeep Ghosh, Amol Patel, Atul Batra, Chandan Krushna Das, TVSVGK Tilak, Bivas Biswas |
Jazyk: |
angličtina |
Rok vydání: |
2020 |
Předmět: |
|
Zdroj: |
Asian Pacific Journal of Cancer Care, Vol 5, Iss S1, Pp 147-152 (2020) |
Druh dokumentu: |
article |
ISSN: |
2588-3682 |
DOI: |
10.31557/apjcc.2020.5.S1.147-152 |
Popis: |
Coronavirus disease (COVID-19) caused by severe acute respiratory syndrome - coronavirus 2 (SARS-CoV-2) has become a pandemic and affected the entire globe. Daily routine life is affected due to global restriction of movement and infected more than 3.7 million peoples in more than 200 countries. It’s an invisible enemy which has imposed a clear threat to the humanity. Patients other than COVID-19 is also suffering a lot due to this unforeseen circumstances. This pandemic also shaken the powerful nations with best of healthcare settings. Oncology is a unique sector of healthcare as cancer patients are at more risk of SARS-CoV-2 infection and cancer treatments are also affected. Many regulatory bodies and professional organizations have come up with guidelines for healthcare personals and patients to guide anti-cancer treatment during COVID-19 pandemic. It’s time to formulate local treatment guidelines to guide cancer treatment with optimum use of healthcare resources at society and national level keeping in mind the load of COVID-19 at the concerned region. We have formulated guidelines to manage genitourinary cancer patients during this pandemic, especially in resource constraint setting with the aim of – optimum treatment of these patients with reduction of risk of contracting SARS-CoV-2 infection without affecting oncological outcome. |
Databáze: |
Directory of Open Access Journals |
Externí odkaz: |
|